Japan-The Netherlands Pharmaceutical Online Conference
|The Netherlands provides an unbeatable location for businesses in the biopharmaceutical industry. The dynamic and thriving Dutch biopharmaceutical sector is characterised by outstanding hubs and clusters linked by first-class physical and digital infrastructure. Home to 2,900 innovative Life Sciences businesses, including 420 biopharmaceutical companies, and the European Medicines Agency (in 2019), the Netherlands is one of the most concentrated Life Science & Health clusters in the world.
How can you as a Japanese Pharmaceutical company benefit from the Pharma ecosystem in the Netherlands and how do you supply your pharmaceutical products to the European patients?
We are pleased to invite you to attend the ‘Japan- The Netherlands Pharmaceutical Online Conference’, which will take place on Thursday 4 June, 9:00 – 11:00 (CEST). The event will be accessible for members in the Netherlands and in Japan.
The conference is organized in collaboration with Holland International Distribution Council (HIDC)/Nederland Distributieland (NDL), with presenters from The Netherlands Foreign Investment Agency (NFIA), O&M Movianto, Baggerman Pharma Consult, Freshfields Bruckhaus Deringer, and Port of Rotterdam.
We have a very interesting programme for you, and would be most delighted to welcome you at this online event on 4 June 2020.
|Date: Thursday 4 June
Time: 9:00 – 11:00 (CEST)
8:30 Registration/Log in
9:00 Welcome & Introduction by Christa de Kemp, Managing Director of Dujat
9:05 Welcome by Remco Buurman, CEO of Holland International Distribution Council (HIDC)/Nederland Distributieland (NDL), and Luc Houben, Chairman of Dujat
9:10 “The Netherlands, a Dynamic Life Sciences and Health Community” by Faiza Mohamed, Project Manager Life Sciences & Health – Invest in Holland
9:25 “The Netherlands is the European logistics hub for your Pharma supply chain” by Jasper Eggebeen, Senior Manager Supply Chain Solutions, HIDC
9:40 “Connecting to the Point of Care across the European Market” by Eric Willems, Business Development Director at O&M Movianto
9:55 “Tax and Regulatory hurdles impacting your Pharmaceutical supply chain for export” by Jens Vaessen, Regulatory Affairs, QP Consultant at Baggerman Pharma Consult
10:10 “The (upcoming) regulatory framework for medical devices” by Paul van den Berg, Partner at Freshfields Bruckhaus Deringer
10:25 “Port of Rotterdam: Shippers & Forwarders Supply Chain Approach – Pharmaceuticals” by Daniel Bollard, Business Manager Shippers and Forwarders, Commercial Department at the Port of Rotterdam
10:55 Closing remarks
11:00 End of event
|How to join:
This online conference will be organized via MS Teams. After registration, you will receive the link to access the live event in a confirmation e-mail.
For a more detailed explanation for first-time users, please refer to this guide on how to access the event on desktop, web or mobile device.